Inactive Instrument

Telferscot Resources Inc Stock Canadian Securities Exchange

Equities

TFS

CA87957T1066

Pharmaceuticals

End-of-day quote Canadian Securities Exchange
- - Intraday chart for Telferscot Resources Inc
Sales 2021 - Sales 2022 0.29 0 0.4 Capitalization 9.99M 0 13.6M
Net income 2021 -4M - -5.45M Net income 2022 -3M - -4.08M EV / Sales 2021 -
Net Debt 2021 75.05K 0 102K Net Debt 2022 1.15M 0 1.56M EV / Sales 2022 37,969,265 x
P/E ratio 2021
-7.9 x
P/E ratio 2022
-2.63 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 86.26%
More Fundamentals * Assessed data
Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and consumers with medical grade solutions. These include once a day and extended-release formulations. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet (ODT). The IR Tablet is a release profile for solid hard tablets. The XR Tablet is a phytocannabinoid vehicle that is designed to directly address the drawbacks and challenges of competing oral delivery systems. ODT is specifically designed to dissolve directly in the patient’s mouth, with an onset of action between five and thirty minutes.
More about the company